Invention Application
- Patent Title: OPTIMIZED ANTI-TL1A ANTIBODIES
-
Application No.: US16694814Application Date: 2019-11-25
-
Publication No.: US20200157203A1Publication Date: 2020-05-21
- Inventor: Jeffry D. Watkins , Cindy T. Dickerson , J. Monty Watkins
- Applicant: Prometheus Biosciences, Inc.
- Main IPC: C07K16/24
- IPC: C07K16/24 ; A61P1/04
Abstract:
Described herein are humanized anti-TL1A antibodies and pharmaceutical compositions for the treatment of inflammatory bowel disease (IBD), such as Crohn's Disease (CD) and ulcerative colitis (UC).
Public/Granted literature
- US10689439B2 Optimized anti-TL1A antibodies Public/Granted day:2020-06-23
Information query
